Miscarriage · Women undergoing IVF/ICSI cycles
It is very uncertain whether glucocorticoid supplementation changes miscarriage rate per woman compared with placebo (very low certainty).
1 finding from 1 review
OHSS · Women undergoing IVF/ICSI cycles
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Side effects per woman · Women undergoing IVF/ICSI cycles
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Live birth rate · Women undergoing ovarian stimulation with gonadotrophins in IVF and ICSI procedures
It is very uncertain whether recombinant luteinizing hormone (rLH) combined with recombinant… changes live birth rate compared with rFSH alone (very low certainty).
1 finding from 1 review
OHSS · Women undergoing ovarian stimulation with gonadotrophins in IVF and ICSI procedures
Recombinant luteinizing hormone (rLH) combined with recombinant… showed no clear difference in OHSS incidence compared with rFSH alone (low certainty).
1 finding from 1 review
Ongoing pregnancy · Women undergoing ovarian stimulation with gonadotrophins in IVF and ICSI procedures
Recombinant luteinizing hormone (rLH) combined with recombinant… probably leads to higher ongoing pregnancy rate compared with rFSH alone (moderate certainty).
1 finding from 1 review
Miscarriage · Women undergoing ovarian stimulation with gonadotrophins in IVF and ICSI procedures
Recombinant luteinizing hormone (rLH) combined with recombinant… showed no clear difference in miscarriage rate compared with rFSH alone (moderate certainty).
1 finding from 1 review
Cancellation rate for low response · Women undergoing ovarian stimulation with gonadotrophins in IVF and ICSI procedures
Recombinant luteinizing hormone (rLH) combined with recombinant… showed no clear difference in cancellation rate for low response compared with rFSH alone (low certainty).
1 finding from 1 review
Cancellation rate for imminent OHSS · Women undergoing ovarian stimulation with gonadotrophins in IVF and ICSI procedures
It is very uncertain whether recombinant luteinizing hormone (rLH) combined with recombinant… changes cancellation rate for imminent OHSS compared with rFSH alone (very low certainty).
1 finding from 1 review
Mean number of gonadotropin ampoules used per woman · Women undergoing controlled ovarian stimulation in IVF and ICSI cycles (poor responders)
1 finding from 1 review
Mean number of oocytes retrieved per woman · Women undergoing controlled ovarian stimulation in IVF and ICSI cycles (poor responders)
1 finding from 1 review
Live birth rate per woman · Women undergoing controlled ovarian stimulation in IVF and ICSI cycles (poor responders)
Clomiphene citrate or letrozole with or without gonadotropins (with… showed no clear difference in live birth per woman compared with gonadotropins (with GnRH agonist or midcycle antagonist) (low certainty).
1 finding from 1 review
Clinical pregnancy rate · Women undergoing controlled ovarian stimulation in IVF and ICSI cycles (poor responders)
Clomiphene citrate or letrozole with or without gonadotropins (with… showed no clear difference in clinical pregnancy rate per woman compared with gonadotropins (with GnRH agonist or midcycle antagonist) (low certainty).
1 finding from 1 review
Cancellation rate per woman · Women undergoing controlled ovarian stimulation in IVF and ICSI cycles (poor responders)
Clomiphene citrate or letrozole with or without gonadotropins (with… may leads to higher cancellation rate per woman compared with gonadotropins (with GnRH agonist or midcycle antagonist) (low certainty).
1 finding from 1 review
Ongoing pregnancy / live birth rate per woman · patients with final oocyte maturation triggering in IVF and ICSI cycles
RhCG showed no clear difference in ongoing pregnancy/live birth rate per woman compared with uhCG (moderate certainty).
1 finding from 1 review
Adverse events per woman · patients with final oocyte maturation triggering in IVF and ICSI cycles
1 finding from 1 review
Moderate or severe OHSS · patients with final oocyte maturation triggering in IVF and ICSI cycles
RhCG showed no clear difference in OHSS per woman ‐ moderate to severe OHSS compared with uhCG (low certainty).
1 finding from 1 review
Clinical pregnancy rate · patients with final oocyte maturation triggering in IVF and ICSI cycles
RhCG showed no clear difference in clinical pregnancy rate per woman compared with uhCG (moderate certainty).
1 finding from 1 review
Miscarriage · patients with final oocyte maturation triggering in IVF and ICSI cycles
RhCG showed no clear difference in miscarriage rate per woman compared with uhCG (low certainty).
1 finding from 1 review
Adverse events per woman · patients with final oocyte maturation triggering in IVF and ICSI cycles
RhCG probably leads to lower adverse events per woman compared with uhCG (moderate certainty).
1 finding from 1 review